The effect of a novel high-adherence weight loss programme in achieving weight loss and other health benefits

The effect of and satisfaction with a novel high-adherence weight loss programme in achieving weight loss and other health benefits in adults with obesity: a retrospective observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN12421711

Enrollment

1000

Registered

2024-10-21

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Nutritional, Metabolic, Endocrine

Interventions

Current methodology as of 21/01/2026: This study is designed to assess the effectiveness and acceptability of a novel weight management programme (the “Programme”). The Programme is structured around

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients who took part in the Programme provided by the treatment centre

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
BMI kg/m² measured using validated weight and self-reported height at baseline and validated weight and self-reported height at monthly intervals. Weight will be validated by directly observing the participant on a weighing-scale by video call.	—

Secondary

Measure	Time frame
1. Patient satisfaction measured using the NHS "Friends and family test" question throughout the duration of the study 2. Frequency, severity and nature of adverse events and side effects measured using an internally-developed side-effect reporting questionnaire throughout the duration of the study 3. Engagement with programme components such as check-ins measured using internal data to determine the percentage of recommended programme activities that the patient completes throughout the study 4. Drop out rate and any reasons provided for leaving the Programme measured using patient self-reporting at the end of the study 5. Weight loss of participants compared to that described in evaluations of other programmes measured using validated weight measurements collected at baseline and at the end of the study	—

Measure

Time frame

1. Patient satisfaction measured using the NHS "Friends and family test" question throughout the duration of the study 2. Frequency, severity and nature of adverse events and side effects measured using an internally-developed side-effect reporting questionnaire throughout the duration of the study 3. Engagement with programme components such as check-ins measured using internal data to determine the percentage of recommended programme activities that the patient completes throughout the study 4. Drop out rate and any reasons provided for leaving the Programme measured using patient self-reporting at the end of the study 5. Weight loss of participants compared to that described in evaluations of other programmes measured using validated weight measurements collected at baseline and at the end of the study

—

Countries

England, United Kingdom, Wales

Contacts

Public ContactMatthew Noble

matthew.noble@emed.com+44 330 303 8000

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 7, 2026